Spinal Restoration, Inc.

14 articles about Spinal Restoration, Inc.

• Spinal Restoration, Inc.'s Biostat® System Fails Phase 3 Test

  7/19/2013

• Spinal Restoration, Inc. Closes $5 Million Round for FDA Submission

  10/23/2012

• Spinal Restoration, Inc. Completes Enrollment of the Phase III Study of the Biostat® System

  7/11/2012

• Spinal Restoration, Inc. Updates the Progress of the Biostat® System and Ongoing Phase III Clinical Study Following the CBS Sunday Morning Segment "A New Hope for Back Pain Sufferers?"

  5/9/2012

• Spinal Restoration, Inc. Receives Patent Allowance for the Biostat® System

  8/23/2011

• Two-Year Outcomes Reported from the FDA Regulated Pilot Study of the Spinal Restoration, Inc. Biostat(R) System

  8/17/2011

• Spinal Restoration, Inc. Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System

  3/16/2010

• Spinal Restoration, Inc. Reaches Agreement with FDA on the Special Protocol Assessment (SPA) for the Phase 3 Trial of the Biostat(R) System

  12/15/2009

• Spinal Restoration, Inc. Announces the Submission of the Investigational Device Exemption (IDE) Pilot Study Results for the Biostat(R) System

  6/9/2009

• Spinal Restoration, Inc. Completes Patient Enrollment in Its Pilot Study of the Biostat® Disc Augmentation System for the Treatment of Discogenic Low Back Pain

  9/9/2008

• Spinal Restoration, Inc. Receives FDA IDE Approval

  5/13/2008

• Spinal Restoration, Inc. Closes $16 Million Series B Financing

  10/9/2007

• Spinal Restoration, Inc. Announces Clinical, Scientific and Business Advisory Boards

  5/1/2007

• Spinal Restoration, Inc. Names Gary E. Sabins as President and CEO

  3/21/2007